Epidemiological Survey on the Current Status of Cochlear Implantation in China
China Cochlear Implant for 30 Years: Epidemiology, Policy Effects and Health Economics Evaluation of Cochlear Implantation in China
1 other identifier
observational
180,000
0 countries
N/A
Brief Summary
Cochlear implantation is an effective intervention for patients with severe to very severe sensorineural hearing loss. By the beginning of 2026, the total number of cochlear implants in China was about 180000. According to the World Health Organization (WHO) survey and data released by the National Bureau of Statistics of China, it is estimated that China's population with severe hearing loss is about 11 million, and the penetration rate is only 1.55. Among them, the adult penetration rate is particularly insufficient, which is far lower than the level of developed countries. In recent years, policy dividends have been intensively introduced in various parts of China. With the update of the rehabilitation service catalog, the price of a single set of cochlear implants in China has plummeted, and cochlear implants have progressed rapidly. At this historical turning point, a systematic analysis of the epidemiology of cochlear implants in my country Characteristics, policy effects and health economics benefits are of great significance for optimizing resource allocation and formulating national hearing care strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 1995
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1995
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
CompletedFirst Submitted
Initial submission to the registry
July 17, 2026
CompletedFirst Posted
Study publicly available on registry
September 15, 2026
CompletedSeptember 17, 2026
September 1, 2026
31.5 years
July 17, 2026
September 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Trends in disease burden of severe/very severe deafness in China and provinces
Based on the data of Chinese cochlear implants, combined with the population with severe hearing loss, the total penetration rate of cochlear implants in China and the trend of changes over the years were calculated. The patients were grouped according to the age at the time of operation.The proportion of each age group in the total population, the change trend of age distribution and gender distribution characteristics were calculated respectively. To construct the medical flow of patients in the provinces of household registration and surgery, Compare the changes in the provincial retention rate and cross-provincial flow of cochlear surgery in China and provinces before and after the collection and medical insurance policy. Set different cochlear implant coverage scenarios, calculate the new demand for the number of surgeries currently completed under the target, quantify the potential service gap, and provide a preliminary planning reference for future cochlear implant services.
from 1995 to 2026
Other Outcomes (1)
Analysis of disease burden and health benefit assessment of severe/very severe deafness
from 1995 to 2026
Study Arms (1)
Chinese cochlear implant patients from 1995 to 2026.
Interventions
Chinese cochlear implant patients from 1995 to 2026
Eligibility Criteria
Patients with severe/very severe sensorineural hearing loss.
You may qualify if:
- Patients who received cochlear implants in Chinese medical institutions between 1995 and 2026;
- Patients with preoperative diagnosis of severe/very severe sensorineural deafness;
- Implantation age ≥ 6 months;
- Records containing at least gender, date of birth, date of surgery, domicile, surgical area, type of implant surgery (first unilateral implant/first bilateral implant/first contralateral implant/re-implant) and implant model information.
You may not qualify if:
- Lack of key information;
- Other devices such as auditory brainstem implants (ABI) or middle ear implants.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chairman Dept of Otolaryngology Head and Neck Surgery Chinese PLA General Hospital
Study Record Dates
First Submitted
July 17, 2026
First Posted
September 15, 2026
Study Start
January 1, 1995
Primary Completion
June 30, 2026
Study Completion
June 30, 2026
Last Updated
September 17, 2026
Record last verified: 2026-09